申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP1683797A1
公开(公告)日:2006-07-26
The compound represented by formula (I)
(wherein D and G are cyclic group which may have a substituent(s) or alkyl which may have a substituent(s), W and Y are a bond or a spacer of which main chain has an atom number of 1-4, ringA and ringB are heterocyclic ring which may have a substituent(s), containing at least one carbon atom and one nitrogen atom and the ringA and ringB share one spiro carbon atom.), a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof Since the compounds represented by formula (I), a salt thereof, an N-oxide thereof or a solvate thereof, or a prodrug thereof have the affinity to MBR, they are useful for the prevention and/or treatment for disease caused by stress.
公式(I)所代表的化合物(其中D和G是可能具有取代基的环族,或者是可能具有取代基的烷基,W和Y是具有1-4个原子编号的主链的键或间隔物,环A和环B是可能具有取代基的杂环,含有至少一个碳原子和一个氮原子,环A和环B共享一个螺环碳原子),其盐,N-氧化物或溶剂合物,或其前药。由于公式(I)所代表的化合物,其盐,N-氧化物或溶剂合物,或其前药对MBR具有亲和力,因此它们对于预防和/或治疗由压力引起的疾病是有用的。